ECM
EW icon

Endurant Capital Management’s Edwards Lifesciences EW Stock Holding History

Endurant Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44,561
Closed -$5.25M – 62
2022
Q1 		$5.25M Buy
+44,561
New +$5M 1.38% 19
2018
Q4 		– Sell
-11,418
Closed -$663K – 60
2018
Q3 		$663K Buy
+11,418
New +$558K 0.29% 58
2018
Q1 		– Sell
-36,648
Closed -$1.38M – 77
2017
Q4 		$1.38M Buy
36,648
+1,800
+5% +$66.1K 0.42% 54
2017
Q3 		$1.27M Sell
34,848
-32,100
-48% -$1.22M 0.38% 62
2017
Q2 		$2.64M Buy
66,948
+3,000
+5% +$110K 0.75% 39
2017
Q1 		$2M Buy
63,948
+32,148
+101% +$1.01M 0.64% 46
2016
Q4 		$993K Buy
+31,800
New +$1.03M 0.41% 50
2015
Q4 		– Sell
-16,200
Closed -$384K – 81
2015
Q3 		$384K Sell
16,200
-50,400
-76% -$1.22M 0.13% 70
2015
Q2 		$1.58M Buy
+66,600
New +$1.5M 0.47% 53

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Endurant Capital Management's EW Position: Q2 2022 in Review

Endurant Capital Management sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 44,561 shares — an estimated $5.25M sold.

Endurant Capital Management first reported a position in EW in Q2 2015 and held it in 9 quarters. The position peaked at $5.25M in Q1 2022. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Endurant Capital Management reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Endurant Capital Management sold 44,561 Edwards Lifesciences shares in Q2 2022, an estimated $5.25M.
  • Endurant Capital Management first reported a position in Edwards Lifesciences in Q2 2015 and held it in 9 quarters.
  • Endurant Capital Management's Edwards Lifesciences position peaked at $5.25M in Q1 2022.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.